MAXCYTE, INC. - 10-Q Filing
MaxCyte, Inc. reports third quarter 2026 financial results including updates on cell engineering technology segment and subsequent debt financing events.
Tickers: $MXCT
MaxCyte, Inc. reports third quarter 2026 financial results including updates on cell engineering technology segment and subsequent debt financing events.
Tickers: $MXCT